PLASMA INTERLEUKIN-6 LEVELS MAY BE ASSOCIATED WITH THE LENGTH OF STAY TIME OF ADULT HYPERGLYCEMIC PATIENTS IN AN INTENSIVE CARE UNIT

Overview

Journal Acta Endocrinol (Buchar)

Specialty Endocrinology

Date 2020 Dec 28

PMID 33363652

Citations 1

Authors

E Uysal

Y A Acar

R Celik

N Nasuhbeyoglu

Affiliations

Soon will be listed here.

Abstract

Context: Estimation of intensive care unit (ICU) length of stay time (LOS) may be challenging, and pro-inflammatory cytokines can be used as a marker for this purpose.

Objective: The current study aimed to investigate the association between pro-inflammatory cytokine levels and LOS in hyperglycemic patients admitted to adult ICU.

Design: This is a prospective observational study.

Subjects And Methods: All adult ICU patients with a blood glucose level higher than 250 mg/dL, during the study period were included. Hospitalization day demographics were recorded, and plasma IL-6, IL1-ß, and TNF-α concentrations were measured.

Results: A total of 74 patients were enrolled in the study. Diabetic ketoacidosis (DKA) was positive in 31 patients, and the remaining 43 were in the non-DKA (NDKA) group. There was no difference between the two groups in terms of age, gender, LOS, hemoglobin, hematocrit, lactate levels, and platelets count. IL-6, IL-1ß, and TNF-α levels did not show any difference between DKA and NDKA groups (p=0.784, 0.413, and 0.288, respectively). There was a positive correlation between IL-6 levels and LOS (n=74, Pearson correlation=0.330; p=0.004).

Conclusions: Among pro-inflammatory cytokines, IL-6 showed a better performance for the prediction of LOS than IL-1ß, TNF-α, and CRP.

Citing Articles

Preoperative C-reactive protein is related with renal cell tumor dimension? Preliminary results.

Miron A, Jinga V, Radavoi G, Proca T, Stan A, Puia D Rom J Morphol Embryol. 2023; 63(4):639-644.

PMID: 36808199 PMC: 10026923. DOI: 10.47162/RJME.63.4.06.

References

Pickup J, Chusney G, Thomas S, Burt D . Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000; 67(3):291-300. DOI: 10.1016/s0024-3205(00)00622-6. View

Hoffman W, Burek C, Waller J, Fisher L, Khichi M, Mellick L . Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol. 2003; 108(3):175-81. DOI: 10.1016/s1521-6616(03)00144-x. View

Stentz F, Umpierrez G, Cuervo R, Kitabchi A . Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004; 53(8):2079-86. DOI: 10.2337/diabetes.53.8.2079. View

Ruge T, Lockton J, Renstrom F, Lystig T, Sukonina V, Svensson M . Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metabolism. 2009; 58(6):860-6. DOI: 10.1016/j.metabol.2009.02.010. View

Karavanaki K, Karanika E, Georga S, Bartzeliotou A, Tsouvalas M, Konstantopoulos I . Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J. 2011; 58(12):1045-53. DOI: 10.1507/endocrj.ej11-0024. View

Davi G, Chiarelli F, Santilli F, Pomilio M, Vigneri S, Falco A . Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation. 2003; 107(25):3199-203. DOI: 10.1161/01.CIR.0000074205.17807.D0. View

Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M . Intensive insulin therapy in critically ill patients. N Engl J Med. 2002; 345(19):1359-67. DOI: 10.1056/NEJMoa011300. View

Hirano T, Taga T, Matsuda T, Hibi M, Suematsu S, Tang B . Interleukin 6 and its receptor in the immune response and hematopoiesis. Int J Cell Cloning. 1990; 8 Suppl 1:155-66; discussion 166-7. DOI: 10.1002/stem.5530080714. View

Kern P, Ranganathan S, Li C, Wood L, Ranganathan G . Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001; 280(5):E745-51. DOI: 10.1152/ajpendo.2001.280.5.E745. View

10.

Siljan W, Holter J, Nymo S, Husebye E, Ueland T, Aukrust P . Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia. Eur J Clin Invest. 2017; 48(1). PMC: 5767742. DOI: 10.1111/eci.12865. View

11.

Shanmugam N, Reddy M, Guha M, Natarajan R . High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes. 2003; 52(5):1256-64. DOI: 10.2337/diabetes.52.5.1256. View

12.

Feigerlova E, Battaglia-Hsu S . IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives. Cytokine Growth Factor Rev. 2017; 37:57-65. DOI: 10.1016/j.cytogfr.2017.03.003. View

13.

Alnek K, Kisand K, Heilman K, Peet A, Varik K, Uibo R . Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes. PLoS One. 2015; 10(12):e0142976. PMC: 4670260. DOI: 10.1371/journal.pone.0142976. View

14.

Heinrich P, Behrmann I, Haan S, Hermanns H, Muller-Newen G, Schaper F . Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003; 374(Pt 1):1-20. PMC: 1223585. DOI: 10.1042/BJ20030407. View

15.

Wiryana M . The role of intensive insulin therapy in increasing superoxide dismutase (SOD) and normalizing hyperglycemia in critically ill patients. Acta Med Indones. 2009; 41(2):59-65. View

16.

Gogos C, Giali S, Paliogianni F, Dimitracopoulos G, Bassaris H, Vagenakis A . Interleukin-6 and C-reactive protein as early markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis. Diabetologia. 2001; 44(8):1011-4. DOI: 10.1007/s001250100592. View

17.

Siddiqui S, Chua M, Kumaresh V, Choo R . A comparison of pre ICU admission SIRS, EWS and q SOFA scores for predicting mortality and length of stay in ICU. J Crit Care. 2017; 41:191-193. DOI: 10.1016/j.jcrc.2017.05.017. View

18.

Chen Y, Qiao Y, Pan Y, Xu Y, Huang Y, Wang Y . Correlation between serum interleukin-6 level and type 1 diabetes mellitus: A systematic review and meta-analysis. Cytokine. 2017; 94:14-20. DOI: 10.1016/j.cyto.2017.01.002. View

19.

Commins S, Borish L, Steinke J . Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol. 2009; 125(2 Suppl 2):S53-72. DOI: 10.1016/j.jaci.2009.07.008. View

20.

Moitra V, Guerra C, Linde-Zwirble W, Wunsch H . Relationship Between ICU Length of Stay and Long-Term Mortality for Elderly ICU Survivors. Crit Care Med. 2015; 44(4):655-62. PMC: 4792682. DOI: 10.1097/CCM.0000000000001480. View